Abstract
The amino acid melanin precursor analogue, p-boronophenylalanine (BPA) has previously been tested in melanoma bearing animals1,2 and used in clinical trials of BNCT.3,4 In the case of melanoma, it is a rational biochemical approach to load the tumour with this precursor analogue, since melanin is synthesised from the amino acid phenylalanine. However, it has been found that BPA can selectively accumulate in tumours other than melanoma; for example, in a murine mammary adenocarcinoma, in a rat glioma, and in a xenografted human glioma.4 The use of BPA has therefore been proposed for BNCT of high grade brain cancer, since it can penetrate the blood brain barrier (BBB), so that it is possible to load the required concentration of boron into the tumour cells. Pharmacokinetic studies of BPA-fructose have been performed in human patients with melanoma or glioma and uptake into cerebral tumours was found to be adequate for BNCT.5,6
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
B.J. Allen, S. Corderoy-Buck, J.L. Mallcsch, K. Crotty, and D.L. Moore, Local control of subcutaneous murine melanoma xenografts in nude mice by neutron capture therapy. Melanoma Res.. 2: 253–2, 1992.
J.A. Coderre, J.D. Glass, R.G. Fairchild, U. Roy, S. Cohen, and I. Fand, Selective targeting of boronophenylalanine to melanoma in BALBíc mice for neutron capture therapy. Cancer Res., 47: 6377–6383, 1987.
Y. Mishima, C. Honda, M. Ichihashi, I I. Obara, J. Hiratsuka, H. Fukuda, T. Karashima, T. Kobayashi, K. Kanda, and K. Yoshino, Treatment of maligant melanoma by single thermal neutron capture therapy with melanoma seeking 1°B-compound. Lancet, 1989, 0: 388–389.
J.A. Coderre, J.D. Glass, R.G. Fairchild, P.L. Micca, I. Fand, and D.D. Joel. Selective delivery of boron by the melanin precursor analogue p-boronphenylalanine to tumors other than melanoma. Cancer Res.. 50: 138–141, 1990.
J.L. Mallesch, D.E. Moore, B.J. Allen, W.H. McCarthy, R. Jones. and W.A. Stening, The pharmacokinetics of p-boronophenylalanine. fructose in human patients with glioma and metastatic melanoma, Int..1. Radiation Oncology Biol. Phys., 28: 1055–1056, 1994.
J.A. Coderre, A phase-1 biodistribution study of p-boronophenylalanine. in “Boron Neutron Capture Therapy,” D. Gabel and R. Moss, eds., Plenum Press, New York. 1992, pp. 564–465.
J.R. Cooper, F.E. Bloom, and R.H. Roth, “The Biochemical Basis of Neuropharmacology.” 6th ed.. Oxford University Press, Oxford, 1991 pp. 1–35.
S.R. Tamat, D.E. Moore, and B.J. Allen, Assay of boron in biological tissues by inductively coupled plasma atomic emission spectrometry, Anal. Cheri., 59: 2161–2164, 1987.
H.A. Meriaty, and B.J. Allen, Optimisation of neutron capture radiography for analysis of boron in tissues. in: A.H. Soloway, R.F. Barth, and D.E. Carpenter, eds., “Advances in Neutron Capture Therapy,” Plenum Press, New York, 1993, pp. 445–448.
S.M. Hsu, L. Raine, and H. Fanger, Use of avidin-biotin-peroxidase conplex (ABC) in inmmunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures, J. Hi.stochem. Cytochem., 29: 577–580, 1981.
W.A. Hunt, T.K. Dalton, and J.H. Darden, Transient alterations in neurotransmitter activity in the caudate nucleus of rat brain after a high dose of ionizing radiation. Radiation Res., 80: 556–562, 1979.
W.A. Hunt, T.K. Dalton, J.A. Joseph, and B.M. Rabin, Reduction of 3-methoxytyramineconcentrations in the caudate nucleus of rats after exposure to high-energy iron particles: evidence for deficits in dopaminergic neurons, Radiation Res., 21: 169–174, 1990.
I. Ferrer, T. Serrano, R. Rivera, M. Olive, M.J. Zujar, and F. Graus, Radiosensitive populations and recovery in X-ray-induced apoptosis in the developing cerebellum, Acta Neuropathologica, 86: 491–500, 1993.
H. Tauchi and S. Sawada, Analysis of mitotic cell death caused by radiation in mouse leukaemia L5178Y cells: apoptosis is the ultimate form of cell death following mitotic failure. Int. J Radiation Biol., 65: 449–55, 1994.
G.W. Casarett, Radiation histopathology, Florida: CRC Press Inc., 1980, pp. 29–38.
J.W. Hopewell, Late radiation damage to the central nervous system: a radiobiological interpretation, Neuropath. Appl. Neurobiology, 5: 329–343, 1979.
J.M. Mallesch, D.E. Moore, M.G. Carolan, K. Narayan, and B.J. Allen, Response of normal and tumor vasculature to boron neutron capture therapy. (These Proceedings)
G.M. Morris, G. Constantine, G. Ross, T.K. Yeung, and J.W. Hopewell, Boron neutron capture therapy: long-term effects on the skin and spinal cord of the rat. Radiation Res., 135: 380–386, 1993.
K.Z. Matalka, R.F. Barth, M.Q. Bailey, D.A. Wilkie, A. Koestner, and J.W. Hopewell, Radiation effects of boron neutron capture therapy on brain, skin, and eye of rats, Int. J. Radiation Oncology Biol. Phys., 28: 1089–1097, 1994.
V.M. Pickel, T.H. Joh, P.M. Field, C.G. Becker, and D.J. Reis, Cellular localisation of tyrosine hydroxylase by immunohistochemistry, J. Histochem. Cvtochem., 23: 1–12, 1975.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Allen, B.J., Setiawan, Y., Moore, D.E., Halliday, G., Harding, T. (1996). Evidence for a Null Effect of L-10BPA Neutron Capture Therapy on Mouse Brain Dopamine Tracts. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_112
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_112
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive